These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7022422)

  • 1. Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension.
    Horowitz JD; Brennan JB; Oliver LE; Harding D; Goble AJ; Louis WJ
    Postgrad Med J; 1981 Feb; 57(664):115-6. PubMed ID: 7022422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Precapillary pulmonary hypertension: effect of Captopril].
    Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B
    G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.
    Rich S; Martinez J; Lam W; Rosen KM
    Br Heart J; 1982 Sep; 48(3):272-7. PubMed ID: 7049203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma].
    Richard C; Ricome JL; Lemoine F; Rimailho A; Lantz O; Auzépy P
    Rev Med Interne; 1983 Jun; 4(2):125-9. PubMed ID: 6351212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril versus hydralazine in primary pulmonary hypertension.
    Poderoso JJ; Biancolini CA; Del Bosco CG; Catalano HN; Peralta JG; Goldenberg DB; Suárez LD
    J Clin Pharmacol; 1983; 23(11-12):563-6. PubMed ID: 6363466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.
    Ikram H; Maslowski AH; Nicholls MG; Espiner EA; Hull FT
    Br Heart J; 1982 Dec; 48(6):541-5. PubMed ID: 6756445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of converting enzyme inhibitor on hepatic blood flow in man.
    Crossley IR; Bihari D; Gimson AE; Westaby D; Richardson PJ; Williams R
    Am J Med; 1984 May; 76(5B):62-5. PubMed ID: 6328986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril in primary pulmonary hypertension.
    Leier CV; Bambach D; Nelson S; Hermiller JB; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Jan; 67(1):155-61. PubMed ID: 6336605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CREST syndrome--successful reduction of pulmonary hypertension by captopril.
    Prouse PJ; Lahiri A; Gumpel JM
    Postgrad Med J; 1984 Oct; 60(708):672-4. PubMed ID: 6387690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is captopril effective in primary pulmonary hypertension?
    Kokubu T; Kazatani Y; Hamada M; Matsuzaki K; Ito T; Nishimura K; Ochi T; Daimon F; Joh T
    Jpn Circ J; 1982 Oct; 46(10):1095-7. PubMed ID: 6750176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC
    Br Med J; 1979 Nov; 2(6198):1106-9. PubMed ID: 229941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril and primary pulmonary hypertension.
    Hughes GS; Porter RS
    Ann Intern Med; 1983 Oct; 99(4):569. PubMed ID: 6354033
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease.
    Niarchos AP; Whitman HH; Goldstein JE; Laragh JH
    Am Heart J; 1982 Oct; 104(4 Pt 1):834-8. PubMed ID: 6751058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of captopril on hemodynamics in patients of chronic obstructive pulmonary disease with pulmonary hypertension].
    Wang S
    Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):545-8. PubMed ID: 8269786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patients.
    Fagard R; Bulpitt C; Lijnen P; Amery A
    Circulation; 1982 Jan; 65(1):33-9. PubMed ID: 6273009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B
    Chest; 1992 Nov; 102(5):1407-12. PubMed ID: 1424860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.